206 related articles for article (PubMed ID: 15662969)
41. Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins.
Kobayashi K; Kato S; Inoue K; Takada M; Kobayashi K
Methods Mol Biol; 2016; 1382():175-86. PubMed ID: 26611586
[TBL] [Abstract][Full Text] [Related]
42. Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors.
Watson DJ; Passini MA; Wolfe JH
Hum Gene Ther; 2005 Jan; 16(1):49-56. PubMed ID: 15703488
[TBL] [Abstract][Full Text] [Related]
43. Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions.
Kahl CA; Pollok K; Haneline LS; Cornetta K
Mol Ther; 2005 Mar; 11(3):470-82. PubMed ID: 15727944
[TBL] [Abstract][Full Text] [Related]
44. Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.
MacKenzie TC; Kobinger GP; Kootstra NA; Radu A; Sena-Esteves M; Bouchard S; Wilson JM; Verma IM; Flake AW
Mol Ther; 2002 Sep; 6(3):349-58. PubMed ID: 12231171
[TBL] [Abstract][Full Text] [Related]
45. Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.
Mühlebach MD; Schmitt I; Steidl S; Stitz J; Schweizer M; Blankenstein T; Cichutek K; Uckert W
J Mol Med (Berl); 2003 Dec; 81(12):801-10. PubMed ID: 14576928
[TBL] [Abstract][Full Text] [Related]
46. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
[TBL] [Abstract][Full Text] [Related]
47. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
48. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
49. Vesicular stomatitis virus G-pseudotyped lentivirus vectors mediate efficient apical transduction of polarized quiescent primary alveolar epithelial cells.
Borok Z; Harboe-Schmidt JE; Brody SL; You Y; Zhou B; Li X; Cannon PM; Kim KJ; Crandall ED; Kasahara N
J Virol; 2001 Dec; 75(23):11747-54. PubMed ID: 11689655
[TBL] [Abstract][Full Text] [Related]
50. Venezuelan equine encephalitis virus glycoprotein pseudotyping confers neurotropism to lentiviral vectors.
Trabalza A; Georgiadis C; Eleftheriadou I; Hislop JN; Ellison SM; Karavassilis ME; Mazarakis ND
Gene Ther; 2013 Jul; 20(7):723-32. PubMed ID: 23171919
[TBL] [Abstract][Full Text] [Related]
51. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
[TBL] [Abstract][Full Text] [Related]
52. Human immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virus.
Kahl CA; Marsh J; Fyffe J; Sanders DA; Cornetta K
J Virol; 2004 Feb; 78(3):1421-30. PubMed ID: 14722297
[TBL] [Abstract][Full Text] [Related]
53. Vesicular stomatitis virus glycoprotein- and Venezuelan equine encephalitis virus-derived glycoprotein-pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors.
Lipinski DM; Barnard AR; Charbel Issa P; Singh MS; De Silva SR; Trabalza A; Eleftheriadou I; Ellison SM; Mazarakis ND; MacLaren RE
Hum Gene Ther; 2014 Jan; 25(1):50-62. PubMed ID: 24125177
[TBL] [Abstract][Full Text] [Related]
54. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
Haas DL; Case SS; Crooks GM; Kohn DB
Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
[TBL] [Abstract][Full Text] [Related]
55. Efficient transduction of equine adipose-derived mesenchymal stem cells by VSV-G pseudotyped lentiviral vectors.
Petersen GF; Hilbert B; Trope G; Kalle W; Strappe P
Res Vet Sci; 2014 Dec; 97(3):616-22. PubMed ID: 25443656
[TBL] [Abstract][Full Text] [Related]
56. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Chinnasamy N; Chinnasamy D; Toso JF; Lapointe R; Candotti F; Morgan RA; Hwu P
Hum Gene Ther; 2000 Sep; 11(13):1901-9. PubMed ID: 10986562
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of the transduction efficiency of a lentiviral vector for neuron-specific retrograde gene delivery through the point mutation of fusion glycoprotein type E.
Kato S; Sugawara M; Kobayashi K; Kimura K; Inoue KI; Takada M; Kobayashi K
J Neurosci Methods; 2019 Jan; 311():147-155. PubMed ID: 30347222
[TBL] [Abstract][Full Text] [Related]
58. Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses.
Hu S; Mohan Kumar D; Sax C; Schuler C; Akkina R
Virology; 2016 Jan; 488():162-8. PubMed ID: 26650691
[TBL] [Abstract][Full Text] [Related]
59. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.
Hanawa H; Kelly PF; Nathwani AC; Persons DA; Vandergriff JA; Hargrove P; Vanin EF; Nienhuis AW
Mol Ther; 2002 Mar; 5(3):242-51. PubMed ID: 11863413
[TBL] [Abstract][Full Text] [Related]
60. Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein.
Carpentier DC; Vevis K; Trabalza A; Georgiadis C; Ellison SM; Asfahani RI; Mazarakis ND
Gene Ther; 2012 Jul; 19(7):761-74. PubMed ID: 21900965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
